Tag: Guy Chamberland

December 4, 2019

Tetra Bio-Pharma Secures Orphan Drug Designation from FDA

The upswing for Tetra Bio-Pharma continues as the firm has now confirmed the FDA gave its delta-9-tetrahydrocannabinol drug an orphan...
November 25, 2019

Tetra Bio-Pharma Jumps Thanks to Trial Restoration

Medical marijuana research firm Tetra Bio-Pharma announced its trial for PPP001 was back in place after a review from the...
June 11, 2019

Tetra Bio-Pharma Subsidiary Finishes Phase 3 Topical Trial

Tetra Bio-Pharma's subsidiary Panag Pharma announced the completion of its Phase 3 clinical trial of a topical, Awaye, treating pain caused by...
April 9, 2019

Tetra Bio-Pharma Resumes Phase 3 Trial

Tetra Bio-Pharma confirmed it resumed its Phase 3 clinical program on cancer patients.
February 12, 2019

Tetra Bio-Pharma Offers Update on Drug Development Program

Tetra Bio-Pharma announced it decided to moved up the development of its second-generation drug inhalation program.
November 6, 2018

Tetra Bio-Pharma Seeks Acquisition of Panag Pharma

Tetra Bio-Pharma announced a non-binding proposal for the acquisition of all issued and outstanding shares in the capital of Panag Pharma.
August 23, 2018

Tetra Bio-Pharma Submits Orphan Drug Applications to FDA

Tetra Bio-Pharma announced the submission of "multiple" orphan drug designation applications to the the FDA for its treatment of various forms of...